Adock

Adock is a Paris-based biotechnology company specializing in AI-driven drug discovery through its advanced molecular docking and virtual screening platform. The company's technology is designed to accelerate the early stages of drug development by enabling the rapid screening of massive chemical libraries—up to billions of molecules—against specific biological targets. By leveraging high-performance algorithms and cloud-based computing, Adock provides precise predictions of binding affinities, helping researchers identify promising lead compounds more efficiently than traditional experimental methods. The platform aims to significantly reduce the time and cost associated with lead identification for pharmaceutical and biotechnology partners.